Olympus Corporation
Notice Regarding Changes in Directors
Olympus Corporation announced that at the Annual General Meeting of Shareholders to be held in June 2026, Jean-Luc Butel and Costa Sarluccos will be appointed as new outside director candidates.
Key Figures
- Number of New Outside Director Candidates: 2 (Jean-Luc Butel, Costa Sarluccos)
- Number of Directors Scheduled to Resign: 2 (Yasuo Takeuchi, Toshihiko Okubo)
- Scheduled Annual General Meeting: June 2026
AI要約
Details of Changes in Directors
At the Nomination Committee held on March 27, 2026, Olympus Corporation resolved to nominate Jean-Luc Butel and Costa Sarluccos as new outside director candidates. Both individuals possess extensive international experience in the healthcare industry as well as expertise in finance and management, and are expected to contribute to enhancing the board’s supervisory functions and improving corporate value. Meanwhile, President and CEO Yasuo Takeuchi and Director Toshihiko Okubo are scheduled to resign. These changes will be finalized upon approval at the Annual General Meeting of Shareholders in June 2026.
Background and Expectations for New Director Candidates
Jean-Luc Butel has held key positions in multiple global healthcare companies and can provide management advice from an international perspective. Costa Sarluccos, a certified public accountant, has experience as a financial officer and possesses high-level expertise as a director. The appointment of both is expected to strengthen Olympus’ governance structure and contribute to sustainable growth and medium- to long-term enhancement of shareholder value.
